Does Your Insurance Cover Rehab?

How Insurance Parity Actually Works

The Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) was a short, elegant piece of legislation: a health plan that offered mental-health and substance-use benefits could not apply financial requirements (copays, deductibles, coinsurance) or treatment limitations (prior authorization, number of visits) more restrictively than it applied to medical-surgical benefits. The practical enforcement of that principle turned out to be enormously more complicated than the legal text suggested, because the way plans actually constrain access is rarely in the explicit benefit design — it is in the "non-quantitative treatment limits," or NQTLs: the prior-authorization protocols, the medical-necessity criteria, the network-provider contracts, the claim-audit thresholds.

For more than a decade, insurers could comply with parity on paper while systematically making addiction treatment harder to access in practice. A plan\'s published "unlimited outpatient mental-health visits" meant nothing if the plan quietly required pre-authorization for every visit after the sixth. A plan\'s "residential SUD benefit" meant nothing if the in-network list contained four facilities in a state with a dozen evidence-based programs.

The Biden-era rule finalized in late 2024, which took full effect in 2025–2026, changed this dynamic. Plans are now required to collect and analyze their own data on NQTLs — to prove, with actual claim and authorization records, that their behavioral-health friction is not worse than their medical-surgical friction. When the comparative analysis shows disparate impact (for example: 60% of addiction-treatment claims get denied for medical necessity vs. 20% of medical-surgical claims), the plan must correct it. This is still early in enforcement, but it has already shifted insurer behavior: facilities report faster authorizations for documented severe SUD cases, fewer "bait-and-switch" denials mid-stay, and shorter appeal timelines.

How to Actually Verify Coverage

The dance most patients and families are forced into — calling the insurance number, being routed to a benefits team that reads from a script, hearing "rehab is covered" without specifics, then discovering at intake that the facility is out of network and the authorization only covers 14 days — is avoidable if you ask specific questions and document the answers. Here is a working script:

1. "What is my in-network coverage for residential substance-use disorder treatment? Specifically: what is the deductible, coinsurance, and out-of-pocket maximum?"
2. "Does my plan require prior authorization for residential SUD admission? If so, how is authorization obtained, and what is the typical turnaround?"
3. "Is there a limit on the number of days of residential care per year or per benefit period? If so, what is the limit, and what is the process for additional days?"
4. "Which medications for opioid use disorder are on my formulary, and at what tier? Specifically: buprenorphine-naloxone, methadone, naltrexone?"
5. "What is my in-network coverage for Intensive Outpatient Programs (IOP) and Partial Hospitalization (PHP)?"
6. "If I need out-of-network treatment because an in-network facility with the appropriate clinical specialty is not available within 25 miles of my home, what is the process for requesting a network exception?"
7. "Can you send me the medical-necessity criteria your plan uses for residential SUD authorization? Under the 2024 parity rules, these should be available on request."

Document the answers in writing if possible. Request a reference number for the call. If you later receive a denial that contradicts what you were told, the written record is leverage.

What to Do When You Are Denied

Denial rates for addiction-treatment claims are higher than for most other medical specialties, and the appeals process — opaque as it is — works often enough that giving up after a first denial is usually a mistake. The key windows:

• Expedited appeal (72 hours) when the patient is currently in treatment and a denial would interrupt care. Most plans must respond within three business days.
• Standard internal appeal (typically 30 days) for non-urgent denials. You generally have 180 days from the denial date to file.
• Second-level internal appeal in many plans after the first appeal is denied.
• External review through the state insurance department or an Independent Review Organization (IRO) once internal appeals are exhausted — typically decided within 45 days.
• Parity-specific enforcement through the federal Department of Labor (for employer plans) or state insurance commissioners for individual and small-group plans. Parity complaints have become meaningfully more productive since 2024.

Most treatment centers that accept commercial insurance have utilization-review staff who draft the clinical portion of first-level appeals on the patient\'s behalf. Ask specifically: "Does your utilization-review team handle insurance appeals on behalf of patients, or is that the patient\'s responsibility?" The answer should be "yes, we handle it." If it is "no," that itself is useful information.

Provider-Specific Guides

Choose your insurance carrier for detailed information on deductibles, plan types, common denial reasons, appeal processes, and frequently-asked questions specific to that insurer:

• Aetna
• BlueCross BlueShield
• Cigna
• UnitedHealthcare
• Humana
• Anthem
• Kaiser Permanente
• TRICARE
• Medicaid
• Medicare

Sources & References

1. CMS. Mental Health Parity and Addiction Equity Act (MHPAEA) overview. cms.gov
2. DOL. MHPAEA 2024 Final Rule. dol.gov
3. Kaiser Family Foundation. Employer Health Benefits Survey, 2024.
4. KFF. Medicaid Coverage of Substance Use Disorder Treatment, 2024.
5. ASAM. The ASAM Criteria, 4th edition.
6. Wit v. United Behavioral Health — 2020 federal court ruling on UHC medical-necessity criteria.

Coverage details vary by specific plan design. Always verify benefits with your insurer or a licensed admissions counselor before admission. Last updated April 2026. Sources: MHPAEA 2024 Final Rule, CMS Parity compliance database, KFF Health Tracking, ASAM Criteria 4e. See our editorial policy.